Clinical Applications of Sunscreens and Formulation Advancements

Sunena; Deepali      Tomar; Sunil      Jawla
doi:10.2174/2589977515666230718124841
Abstract

Sunscreens cover the big market ratio in terms of cosmetic applications, but the therapeutic necessity of sunscreen still needs to be uncovered in the clinical context. Clinically, sunscreens are being employed more often nowadays as a result of the rising consequences of skin malignancies and the photodamaging effects of UV radiation. Sunscreens are essential to prevent aging by shielding the skin from the harmful effects of ultraviolet (UV) radiation. Over the recent decades, there has been a significant evolution in the usage of sunscreens as photo protectants. The demand for sunscreen formulations will inevitably rise as more people become aware of the protection that sunscreens provide against tanning, photoaging, non-melanoma skin cancers, premalignant skin lesions, and skin melanomas. The novel contemporary formulation techniques are also beneficial in enhancing the product's aesthetic look and quality. Recently, regulatory agencies have also started paying attention to the regulation of the clinical application, efficacy, and safety parameters related to sunscreen. This review underlines the pathophysiological response of UV exposure with the therapeutic applications of sunscreen in various dermatological conditions and the recent formulation advancements in the development of sunscreen.
Keywords: Sunscreen, cosmetics, photoprotection, melanoma, sunburns, UV radiation.
« Previous Next »
Graphical Abstract

[1]
Sambandan DR, Ratner D. Sunscreens: An overview and update. J Am Acad Dermatol  2011; 64(4): 748-58.
 [http://dx.doi.org/10.1016/j.jaad.2010.01.005] [PMID:  21292345]

[2]
Latha MS, Martis J, Shobha V, et al. Sunscreening agents: A review. J Clin Aesthet Dermatol  2013; 6(1): 16-26.
 [PMID:  23320122]

[3]
Moore C, Cevikbas F, Pasolli HA, et al. UVB radiation generates sunburn pain and affects skin by activating epidermal TRPV4 ion channels and triggering endothelin-1 signaling. Proc Natl Acad Sci  2013; 110(34): E3225-34.
 [http://dx.doi.org/10.1073/pnas.1312933110] [PMID:  23929777]

[4]
Harrison SC, Bergfeld WF. Ultraviolet light and skin cancer in athletes. Sports Health  2009; 1(4): 335-40.
 [http://dx.doi.org/10.1177/1941738109338923] [PMID:  23015891]

[5]
Hughes MCB, Williams GM, Baker P, Green AC. Sunscreen and prevention of skin aging: A randomized trial. Ann Intern Med  2013; 158(11): 781-90.
 [http://dx.doi.org/10.7326/0003-4819-158-11-201306040-00002] [PMID:  23732711]

[6]
Brenner M, Hearing VJ. The protective role of melanin against UV damage in human skin. Photochem Photobiol  2008; 84(3): 539-49.
 [http://dx.doi.org/10.1111/j.1751-1097.2007.00226.x] [PMID:  18435612]

[7]
Damiani E, Puglia C. Nanocarriers and microcarriers for enhancing the UV protection of sunscreens: An overview. J Pharm Sci  2019; 108(12): 3769-80.
 [http://dx.doi.org/10.1016/j.xphs.2019.09.009] [PMID:  31521640]

[8]
 Melanoma: Risk Factors and Prevention. Available from:
          https://www.cancer.net/cancer-types/melanoma/risk-factors-and-prevention

[9]
Tomas D. Apoptosis, UV-radiation, precancerosis and skin tumors. Acta Med Croatica  2009; 63(S2): 53-8.
 [PMID:  19999548]

[10]
Radiation: Ultraviolet (UV) radiation and skin cancer.  World Health Organization 2017; p. 16.

[11]
D’Orazio J, Jarrett S, Amaro-Ortiz A, Scott T. UV radiation and the skin. Int J Mol Sci  2013; 14(6): 12222-48.
 [http://dx.doi.org/10.3390/ijms140612222] [PMID:  23749111]

[12]
Rezende SG, Dourado JG, Amorim De Lino FM, Vinhal DC, Silva EC, Gil EDS. Methods used in evaluation of the sun protection factor of sunscreens. Revista Eletrônica de Farmácia  2014; 11(2): 18.
 [http://dx.doi.org/10.5216/ref.v11i2.27013]

[13]
Moyal D, Wichrowski K, Tricaud C. in vivo persistent pigment darkening method: A demonstration of the reproducibility of the UVA protection factors results at several testing laboratories. Photodermatol Photoimmunol Photomed  2006; 22(3): 124-8.
 [http://dx.doi.org/10.1111/j.1600-0781.2006.00223.x] [PMID:  16719864]

[14]
Gilchrest BA, Eller MS, Geller AC, Yaar M. The pathogenesis of melanoma induced by ultraviolet radiation. N Engl J Med  1999; 340(17): 1341-8.
 [http://dx.doi.org/10.1056/NEJM199904293401707] [PMID:  10219070]

[15]
Gies P, Roy C, Udelhofen P. Solar and ultraviolet radiation.In: Prevention of skin cancer.  Dordrecht: Springer 2004; pp. 21-54.
 [http://dx.doi.org/10.1007/978-94-017-0511-0_3]

[16]
Matts PJ, Alard V, Brown MW, et al. The COLIPA in vitro UVA method: A standard and reproducible measure of sunscreen UVA protection. Int J Cosmet Sci  2010; 32(1): 35-46.
 [http://dx.doi.org/10.1111/j.1468-2494.2009.00542.x] [PMID:  20412201]

[17]
Ullrich SE. Photoimmune suppression and photocarcinogenesis. Front Biosci  2002; 7(4): A804.
 [http://dx.doi.org/10.2741/A804] [PMID:  11861222]

[18]
Ziegler A, Jonason AS, Leffellt DJ, et al. Sunburn and p53 in the onset of skin cancer. Nature  1994; 372(6508): 773-6.
 [http://dx.doi.org/10.1038/372773a0] [PMID:  7997263]

[19]
Stoebner PE, Poosti R, Djoukelfit K, Martinez J, Meunier L. Decreased human epidermal antigen-presenting cell activity after ultraviolet A exposure: dose–response effects and protection by sunscreens. Br J Dermatol  2007; 156(6): 1315-20.
 [http://dx.doi.org/10.1111/j.1365-2133.2007.07895.x] [PMID:  17535231]

[20]
De Fabo EC. Arctic stratospheric ozone depletion and increased UVB radiation: potential impacts to human health. Int J Circumpolar Health  2005; 64(5): 509-22.
 [http://dx.doi.org/10.3402/ijch.v64i5.18032] [PMID:  16440613]

[21]
Yousef Hani, Alhajj Mandy, Sharma Sandeep. Anatomy, skin (integument), epidermis. StatPearls 2017.

[22]
Cichorek M, Wachulska M, Stasiewicz A, Tymińska A. Skin melanocytes: Biology and development. Postepy Dermatol Alergol  2013; 30(1): 30-41.
 [http://dx.doi.org/10.5114/pdia.2013.33376]

[23]
Haass NK, Herlyn M. Normal human melanocyte homeostasis as a paradigm for understanding melanoma. J Investig Dermatol Symp Proc  2005; 10(2): 153-63.
 [http://dx.doi.org/10.1111/j.1087-0024.2005.200407.x]

[24]
Markiewicz E, Idowu O. Melanogenic difference consideration in ethnic skin type: A balance approach between skin brightening applications and beneficial sun exposure. Clin Cosmet Investig Dermatol  2020; 13: 215-32.
 [http://dx.doi.org/10.2147/CCID.S245043] [PMID:  32210602]

[25]
Grimes PE. Management of hyperpigmentation in darker racial ethnic groups. Semin Cutan Med Surg  2009; 28(2): 77-85.
 [http://dx.doi.org/10.1016/j.sder.2009.04.001]

[26]
Young AR. Chromophores in human skin. Phys Med Biol  1997; 42(5): 789-802.
 [http://dx.doi.org/10.1088/0031-9155/42/5/004] [PMID:  9172259]

[27]
Halder RM, Nootheti PK. Ethnic skin disorders overview. J Am Acad Dermatol  2003; 48(6): S143-8.
 [http://dx.doi.org/10.1067/mjd.2003.274] [PMID:  12789168]

[28]
Eun HC. Cutaneous photodamage in asians. J Dermatol  2001; 28(11): 614-6.
 [http://dx.doi.org/10.1111/j.1346-8138.2001.tb00045.x] [PMID:  11770717]

[29]
Ito S, Wakamatsu K, Ozeki H. Chemical analysis of melanins and its application to the study of the regulation of melanogenesis. Pigment Cell Res  2000; 13(S8): 103-9.
 [http://dx.doi.org/10.1034/j.1600-0749.13.s8.19.x] [PMID:  11041366]

[30]
Vincensi MR, d’Ischia M, Napolitano A, et al. Phaeomelanin versus eumelanin as a chemical indicator of ultraviolet sensitivity in fair-skinned subjects at high risk for melanoma: A pilot study. Melanoma Res  1998; 8(1): 53-8.
 [http://dx.doi.org/10.1097/00008390-199802000-00009] [PMID:  9508377]

[31]
Elwood JM, Diffey BL. A consideration of ambient solar ultraviolet radiation in the interpretation of studies of the aetiology of melanoma. Melanoma Res  1993; 3(2): 113-22.
 [PMID:  8518549]

[32]
Holcomb NC, Bautista RM, Jarrett SG, Carter KM, Gober MK, D’Orazio JA. cAMP-mediated regulation of melanocyte genomic instability: A melanoma-preventive strategy. Adv Protein Chem Struct Biol  2019; 115: 247-95.
 [http://dx.doi.org/10.1016/bs.apcsb.2018.10.008] [PMID:  30798934]

[33]
Rastogi RP, Richa KA, Kumar A, Tyagi MB, Sinha RP. Molecular mechanisms of ultraviolet radiation-induced DNA damage and repair. J Nucleic Acids  2010; 2010: 1-32.
 [http://dx.doi.org/10.4061/2010/592980] [PMID:  21209706]

[34]
Ravnbak MH. Objective determination of Fitzpatrick skin type. Dan Med Bull  2010; 57(8): B4153.
 [PMID:  20682135]

[35]
Kim K, Park H, Lim KM. Phototoxicity: Its mechanism and animal alternative test methods. Toxicol Res  2015; 31(2): 97-104.
 [http://dx.doi.org/10.5487/TR.2015.31.2.097] [PMID:  26191378]

[36]
Goncalo M. Phototoxic and photoallergic reactions InContact dermatitis.  Berlin, Heidelberg: Springer 2011; pp. 361-76.

[37]
Alscher RG, Donahue JL, Cramer CL. Reactive oxygen species and antioxidants: Relationships in green cells. Physiol Plant  1997; 100(2): 224-33.
 [http://dx.doi.org/10.1111/j.1399-3054.1997.tb04778.x]

[38]
Lugović L, Situm M, Ozanić-Bulić S, Sjerobabski-Masnec I. Phototoxic and photoallergic skin reactions. Coll Antropol  2007; 31(1): 63-7.
 [PMID:  17469754]

[39]
Widgerow AD, Napekoski K. New approaches to skin photodamage histology-Differentiating ‘good’ versus ‘bad’ Elastin. J Cosmet Dermatol  2021; 20(2): 526-31.
 [http://dx.doi.org/10.1111/jocd.13865] [PMID:  33251676]

[40]
Hölzle E, Hönigsmann H. UV-radiation-sources, wavelength, environment. J Dtsch Dermatol Ges  2005; 3(S2): S3-S10.
 [http://dx.doi.org/10.1111/j.1610-0387.2005.04392.x] [PMID:  16117741]

[41]
Marks R. Epidemiology of melanoma: Clinical dermatology. Clinical and Experimental Dermatology. Clin Dermatol  2000; 25(6): 459-63.

[42]
Tatalovich Z, Wilson JP, Mack T, Yan Y, Cockburn M. The objective assessment of lifetime cumulative ultraviolet exposure for determining melanoma risk. J Photochem Photobiol B  2006; 85(3): 198-204.
 [http://dx.doi.org/10.1016/j.jphotobiol.2006.08.002] [PMID:  16963272]

[43]
Chen X, Yang C, Jiang G. Research progress on skin photoaging and oxidative stress. Postepy Dermatol Alergol  2021; 38(6): 931-6.
 [http://dx.doi.org/10.5114/ada.2021.112275] [PMID:  35125996]

[44]
Garland CF, Garland FC, Gorham ED. Rising trends in melanoma an hypothesis concerning sunscreen effectiveness. Ann Epidemiol  1993; 3(1): 103-10.
 [http://dx.doi.org/10.1016/1047-2797(93)90017-X] [PMID:  8287144]

[45]
Boyle P, Maisonneuve P, Doré J-F. Epidemiology of malignant melanoma. Br Med Bull  1995; 51(3): 523-47.
 [http://dx.doi.org/10.1093/oxfordjournals.bmb.a072978] [PMID:  7552080]

[46]
Liu T, Soong S. Epidemiology of malignant melanoma. Surg Clin North Am  1996; 76(6): 1205-22.
 [http://dx.doi.org/10.1016/S0039-6109(05)70511-9] [PMID:  8977547]

[47]
Qureshi AA, Laden F, Colditz GA, Hunter DJ. Geographic variation and risk of skin cancer in US women. Differences between melanoma, squamous cell carcinoma, and basal cell carcinoma. Arch Intern Med  2008; 168(5): 501-7.
 [http://dx.doi.org/10.1001/archinte.168.5.501] [PMID:  18332296]

[48]
Freitas-Rodríguez S, Folgueras AR, López-Otín C. The role of matrix metalloproteinases in aging: Tissue remodeling and beyond. Biochim Biophys Acta Mol Cell Res  2017; 1864(11): 2015-25.
 [http://dx.doi.org/10.1016/j.bbamcr.2017.05.007] [PMID:  28499917]

[49]
Sorrell JM, Caplan AI. Fibroblast heterogeneity: More than skin deep. J Cell Sci  2004; 117(5): 667-75.
 [http://dx.doi.org/10.1242/jcs.01005] [PMID:  14754903]

[50]
Berneburg M, Grether-Beck S, Kürten V, et al. Singlet oxygen mediates the UVA-induced generation of the photoaging-associated mitochondrial common deletion. J Biol Chem  1999; 274(22): 15345-9.
 [http://dx.doi.org/10.1074/jbc.274.22.15345] [PMID:  10336420]

[51]
Gremmel T, Wild S, Schuller W, et al. Six genes associated with the clinical phenotypes of individuals with deficient and proficient DNA repair. Transl Oncogenomics  2008; 3: 1-13.
 [PMID:  21566739]

[52]
Aberer W, Schuler G, Stingl G, Hönigsmann H, Wolff K. Ultraviolet light depletes surface markers of Langerhans cells. J Invest Dermatol  1981; 76(3): 202-10.
 [http://dx.doi.org/10.1111/1523-1747.ep12525745] [PMID:  6453905]

[53]
Stingl G, Gazze-Stingl LA, Aberer W, Wolff K. Antigen presentation by murine epidermal langerhans cells and its alteration by ultraviolet B light. J Immunol  1981; 127(4): 1707-13.
 [http://dx.doi.org/10.4049/jimmunol.127.4.1707] [PMID:  6168700]

[54]
Aberer W, Leibl H. Effect of UVB radiation on the biosynthesis of HLA-DR antigens. Arch Dermatol Res  1987; 279(5): 321-6.
 [http://dx.doi.org/10.1007/BF00431225] [PMID:  3498445]

[55]
Schwarz A, Noordegraaf M, Maeda A, Torii K, Clausen BE, Schwarz T. Langerhans cells are required for UVR-induced immunosuppression. J Invest Dermatol  2010; 130(5): 1419-27.
 [http://dx.doi.org/10.1038/jid.2009.429] [PMID:  20090769]

[56]
Schwarz T, Schwarz A. Molecular mechanisms of ultraviolet radiation-induced immunosuppression. Eur J Cell Biol  2011; 90(6-7): 560-4.
 [http://dx.doi.org/10.1016/j.ejcb.2010.09.011] [PMID:  21035896]

[57]
Krystel-Whittemore M, Dileepan KN, Wood JG. Mast cell: A multi-functional master cell. Front Immunol  2016; 6: 620.
 [http://dx.doi.org/10.3389/fimmu.2015.00620] [PMID:  26779180]

[58]
Lavker RM. Structural alterations in exposed and unexposed aged skin. J Invest Dermatol  1979; 73(1): 59-66.
 [http://dx.doi.org/10.1111/1523-1747.ep12532763] [PMID:  448178]

[59]
Eschenfelder CC, Benrath J, Zimmermann M, Gillardon F. Involvement of substance P in ultraviolet irradiation-induced inflammation in rat skin. Eur J Neurosci  1995; 7(7): 1520-6.
 [http://dx.doi.org/10.1111/j.1460-9568.1995.tb01147.x] [PMID:  7551178]

[60]
Kulka M, Sheen CH, Tancowny BP, Grammer LC, Schleimer RP. Neuropeptides activate human mast cell degranulation and chemokine production. Immunology  2008; 123(3): 398-410.
 [http://dx.doi.org/10.1111/j.1365-2567.2007.02705.x] [PMID:  17922833]

[61]
Sheen CH, Schleimer RP, Kulka M. Codeine induces human mast cell chemokine and cytokine production: Involvement of G-protein activation. Allergy  2007; 62(5): 532-8.
 [http://dx.doi.org/10.1111/j.1398-9995.2007.01345.x] [PMID:  17441793]

[62]
McCary C, Tancowny BP, Catalli A, et al. Substance P downregulates expression of the high affinity IgE receptor (FcεRI) by human mast cells. J Neuroimmunol  2010; 220(1-2): 17-24.
 [http://dx.doi.org/10.1016/j.jneuroim.2009.12.006] [PMID:  20117843]

[63]
Tancowny BP, Karpov V, Schleimer RP, Kulka M. Substance P primes lipoteichoic acid- and Pam3CysSerLys4-mediated activation of human mast cells by up-regulating Toll-like receptor 2. Immunology  2010; 131(2): 220-30.
 [http://dx.doi.org/10.1111/j.1365-2567.2010.03296.x] [PMID:  20497485]

[64]
Hart PH, Grimbaldeston MA, Swift GJ, Jaksic A, Noonan FP, Finlay-Jones JJ. Dermal mast cells determine susceptibility to ultraviolet B-induced systemic suppression of contact hypersensitivity responses in mice. J Exp Med  1998; 187(12): 2045-53.
 [http://dx.doi.org/10.1084/jem.187.12.2045] [PMID:  9625764]

[65]
Bosset S, Barré P, Chalon A, et al. Skin ageing: Clinical and histopathologic study of permanent and reducible wrinkles. Eur J Dermatol  2002; 12(3): 247-52.
 [PMID:  11978565]

[66]
Bosset S, Bonnet-Duquennoy M, Barré P, et al. Photoageing shows histological features of chronic skin inflammation without clinical and molecular abnormalities. Br J Dermatol  2003; 149(4): 826-35.
 [http://dx.doi.org/10.1046/j.1365-2133.2003.05456.x] [PMID:  14616376]

[67]
Bosset S, Bonnet-Duquennoy M, Barré P, et al. Decreased expression of keratinocyte β1 integrins in chronically sun-exposed skin in vivo. Br J Dermatol  2003; 148(4): 770-8.
 [http://dx.doi.org/10.1046/j.1365-2133.2003.05159.x] [PMID:  12752137]

[68]
Yan Y, Wang B, Zuo Y, Qu T. Inhibitory effects of mizolastine on ultraviolet B-induced leukotriene B4 production and 5-lipoxygenase expression in normal human dermal fibroblasts in vitro. Photochem Photobiol  2006; 82(3): 665-9.
 [http://dx.doi.org/10.1562/2005-08-17-RA-652] [PMID:  16402861]

[69]
Ma LJ, Guzmán EA, DeGuzman A, et al. Unexpected effects of UVB in IL-10 transgenic mice: Normalization of contact hypersensitivity response. Arch Dermatol Res  2006; 297(9): 417-20.
 [http://dx.doi.org/10.1007/s00403-005-0634-0] [PMID:  16389560]

[70]
Rai R, Srinivas CR. Photoprotection. Indian J Dermatol Venereol Leprol  2007; 73(2): 73-79.21.

[71]
 Guidance for Industry. Enforcement Policy-OTC Sunscreen Drug Products Marketed Without an Approved Application. 2011. Available from:
          http://www.fda.gov/downloads/Drugs/Guidance Compliance Regulatory Information/Guidances/UCM259001.pdf(Accessed August 01, 2022).

[72]
 Over-the-Counter Monograph M020: Sunscreen Drug Products for Over-the-Counter Human Use. 2011. Available from:
          https://dps-admin.fda.gov/omuf/omuf/sites/omuf/files/primary-docum
ents/2022-09/Final%20Administrative%20Order%20OTC000006_M0
20-Sunscreen%20Drug%20Products%20for%20OTC%20Human%
20Use.pdf

[73]
Johansen JD, Frosch PJ, Lepoittevin JP. Eds Contact dermatitis. Springer Science & Business Media 2010.

[74]
Singhal M, Khanna S, Nasa AT. Cosmeceuticals for the skin: An overview. Asian J Pharm Clin Res  2011; 4(2): 1-6.

[75]
Bodekaer M, Faurschou A, Philipsen PA, Wulf HC. Sun protection factor persistence during a day with physical activity and bathing. Photodermatol Photoimmunol Photomed  2008; 24(6): 296-300.
 [http://dx.doi.org/10.1111/j.1600-0781.2008.00379.x] [PMID:  19000186]

[76]
Schalka S, dos Reis VMS, Cucé LC. The influence of the amount of sunscreen applied and its sun protection factor (SPF): Evaluation of two sunscreens including the same ingredients at different concentrations. Photodermatol Photoimmunol Photomed  2009; 25(4): 175-80.
 [http://dx.doi.org/10.1111/j.1600-0781.2009.00408.x] [PMID:  19614894]

[77]
Kim SM, Oh BH, Lee YW, Choe YB, Ahn KJ. The relation between the amount of sunscreen applied and the sun protection factor in Asian skin. J Am Acad Dermatol  2010; 62(2): 218-22.
 [http://dx.doi.org/10.1016/j.jaad.2009.06.047] [PMID:  19962787]

[78]
Peres DDA, Ariede MB, Candido TM, et al. Quality by design (QbD), process analytical technology (PAT), and design of experiment applied to the development of multifunctional sunscreens. Drug Dev Ind Pharm  2017; 43(2): 246-56.
 [http://dx.doi.org/10.1080/03639045.2016.1236809] [PMID:  27627681]

[79]
Geoffrey K, Mwangi AN, Maru SM. Sunscreen products: Rationale for use, formulation development and regulatory considerations. Saudi Pharm J  2019; 27(7): 1009-18.
 [http://dx.doi.org/10.1016/j.jsps.2019.08.003] [PMID:  31997908]

[80]
Sander M, Sander M, Burbidge T, Beecker J. The efficacy and safety of sunscreen use for the prevention of skin cancer. CMAJ  2020; 192(50): E1802-8.
 [http://dx.doi.org/10.1503/cmaj.201085] [PMID:  33318091]

[81]
Aziz ZAA, Mohd-Nasir H, Ahmad A, et al. Role of nanotechnology for design and development of cosmeceutical: Application in makeup and skin care. Front Chem  2019; 7: 739.
 [http://dx.doi.org/10.3389/fchem.2019.00739] [PMID:  31799232]

[82]
Smijs T, Pavel S. Titanium dioxide and zinc oxide nanoparticles in sunscreens: Focus on their safety and effectiveness. Nanotechnol Sci Appl  2011; 4: 95-112.
 [http://dx.doi.org/10.2147/NSA.S19419] [PMID:  24198489]

[83]
Montenegro L, Carbone C, Puglisi G. Vehicle effects on in vitro release and skin permeation of octylmethoxycinnamate from microemulsions. Int J Pharm  2011; 405(1-2): 162-8.
 [http://dx.doi.org/10.1016/j.ijpharm.2010.11.036]

[84]
Netto MPharm G, Jose J. Development, characterization, and evaluation of sunscreen cream containing solid lipid nanoparticles of silymarin. J Cosmet Dermatol  2018; 17(6): 1073-83.
 [http://dx.doi.org/10.1111/jocd.12470] [PMID:  29226503]

[85]
Mestres JP, Duracher L, Baux C, Vian L, Marti-Mestres G. Benzophenone-3 entrapped in solid lipid microspheres: Formulation and in vitro skin evaluation. Int J Pharm  2010; 400(1-2): 1-7.
 [http://dx.doi.org/10.1016/j.ijpharm.2010.07.028] [PMID:  20670679]

[86]
Gause S, Chauhan A. Broad spectrum UV protection by crystalline organic microrod sunscreens. Int J Pharm  2015; 489(1-2): 30-44.
 [http://dx.doi.org/10.1016/j.ijpharm.2015.04.027] [PMID:  25886802]

[87]
Huang X, Wang X, Wang S, Yang J, Zhong L, Pan J. UV and dark-triggered repetitive release and encapsulation of benzophenone-3 from biocompatible ZnO nanoparticles potential for skin protection. Nanoscale  2013; 5(12): 5596-601.
 [http://dx.doi.org/10.1039/c3nr00090g] [PMID:  23680782]

[88]
Chrétien MN, Heafey E, Scaiano JC. Reducing adverse effects from UV sunscreens by zeolite encapsulation: comparison of oxybenzone in solution and in zeolites. Photochem Photobiol  2010; 86(1): 153-61.
 [http://dx.doi.org/10.1111/j.1751-1097.2009.00644.x] [PMID:  19930122]

[89]
Sanad RA, AbdelMalak NS, elBayoomy TS, Badawi AA. Formulation of a novel oxybenzone-loaded nanostructured lipid carriers (NLCs). AAPS PharmSciTech  2010; 11(4): 1684-94.
 [http://dx.doi.org/10.1208/s12249-010-9553-2] [PMID:  21107771]

[90]
Gilbert E, Roussel L, Serre C, et al. Percutaneous absorption of benzophenone-3 loaded lipid nanoparticles and polymeric nanocapsules: A comparative study. Int J Pharm  2016; 504(1-2): 48-58.
 [http://dx.doi.org/10.1016/j.ijpharm.2016.03.018] [PMID:  26976501]

[91]
Badea G, Lacatusu I, Ott C, Badea N, Grafu I, Meghea A. Integrative approach in prevention and therapy of basal cellular carcinoma by association of three actives loaded into lipid nanocarriers. J Photochem Photobiol B  2015; 147: 1-8.
 [http://dx.doi.org/10.1016/j.jphotobiol.2015.03.007] [PMID:  25828466]

[92]
Villalobos-Hernandez JR, Muller-Goymann CC. Novel nanoparticulate carrier system based on carnauba wax and decyl oleate for the dispersion of inorganic sunscreens in aqueous media. Euro J Pharm Biopharm 2005; 60(1):113-122. Nesseem D. Formulation of sunscreens with enhancement sun protection factor response based on solid lipid nanoparticles. Int J Cosmet Sci  2011; 33(1): 70-9.
 [PMID:  20704600]

[93]
Lee YJ, Nam GW. Sunscreen boosting effect by solid lipid nanoparticles-loaded fucoxanthin formulation. Cosmetics  2020; 7(1): 14.
 [http://dx.doi.org/10.3390/cosmetics7010014]

[94]
Sanju N, Vineet M, Kumud M. Development and evaluation of a broad spectrum polyherbal sunscreen formulation using solid lipid nanoparticles of safranal. J Cosmet Dermatol  2022; 21(10): 4433-46.
 [http://dx.doi.org/10.1111/jocd.14777] [PMID:  35034408]

[95]
Tolbert SH, McFadden PD, Loy DA. New hybrid organic/inorganic polysilsesquioxane–silica particles as sunscreens. ACS Appl Mater Interfaces  2016; 8(5): 3160-74.
 [http://dx.doi.org/10.1021/acsami.5b10472] [PMID:  26730573]

[96]
Andreani T, Dias-Ferreira J, Fangueiro JF, et al. Formulating octyl methoxycinnamate in hybrid lipid-silica nanoparticles: An innovative approach for UV skin protection. Heliyon  2020; 6(5)e03831
 [http://dx.doi.org/10.1016/j.heliyon.2020.e03831] [PMID:  32395645]

[97]
Zaccariello G, Back M, Zanello M, et al. Formation and controlled growth of bismuth titanate phases into mesoporous silica nanoparticles: An efficient self-sealing nanosystem for UV filtering in cosmetic formulation. ACS Appl Mater Interfaces  2017; 9(2): 1913-21.
 [http://dx.doi.org/10.1021/acsami.6b13252] [PMID:  28001044]

[98]
Olson E, Li Y, Lin FY, et al. Thin biobased transparent UV-blocking coating enabled by nanoparticle self-assembly. ACS Appl Mater Interfaces  2019; 11(27): 24552-9.
 [http://dx.doi.org/10.1021/acsami.9b05383] [PMID:  31246398]

[99]
Arianto A, Cella G, Bangun H. Preparation and evaluation of sunscreen nanoemulsions with synergistic efficacy on SPF by combination of soybean oil, avobenzone, and octyl methoxycinnamate. Open Access Maced J Med Sci  2019; 7(17): 2751-6.
 [http://dx.doi.org/10.3889/oamjms.2019.745] [PMID:  31844431]

[100]
Nesseem D. Formulation of sunscreens with enhancement sun protection factor response based on solid lipid nanoparticles. Int J Cosmet Sci  33(1): 70-9.
 [http://dx.doi.org/10.1111/j.1468-2494.2010.00598.x]

[101]
Couvreur P, Barratt G, Fattal E, Vauthier C. Nanocapsule technology: A review. Crit Rev Ther Drug Carrier Syst  2002; 19(2): 99-134.
 [http://dx.doi.org/10.1615/CritRevTherDrugCarrierSyst.v19.i2.10]

[102]
Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release  2001; 70(1-2): 1-20.
 [http://dx.doi.org/10.1016/S0168-3659(00)00339-4] [PMID:  11166403]

[103]
Dash TK, Konkimalla VB. Poly-є-caprolactone based formulations for drug delivery and tissue engineering: A review. J Control Release  2012; 158(1): 15-33.

[104]
Perugini P, Simeoni S, Scalia S, et al. Effect of nanoparticle encapsulation on the photostability of the sunscreen agent, 2-ethylhexyl-p-methoxycinnamate. Int J Pharm  2002; 246(1-2): 37-45.
 [http://dx.doi.org/10.1016/S0378-5173(02)00356-3] [PMID:  12270607]

[105]
Lorca BS, Bessa ES, Nele M, Santos EP, Pinto JC. Preparation of PMMA nanoparticles loaded with benzophenone 3 through miniemulsion polymerization. Brazilian Polymer Conference  2012; 319(1)
 [http://dx.doi.org/10.1002/masy.201100252]

[106]
Lapidot N, Gans O, Biagini F, Sosonkin L, Rottman C. Advanced sunscreens: UV absorbers encapsulated in sol-gel glass microcapsules. J Sol-Gel Sci Technol  2003; 26(1/3): 67-72.
 [http://dx.doi.org/10.1023/A:1020785217895]

[107]
Li CC, Lin YT, Chen YT, Sie SF, Chen-Yang YW. Improvement in UV protection retention capability and reduction in skin penetration of benzophenone-3 with mesoporous silica as drug carrier by encapsulation. J Photochem Photobiol B  2015; 148: 277-83.
 [http://dx.doi.org/10.1016/j.jphotobiol.2015.04.027] [PMID:  25985148]

[108]
Zhang J, Raphael AP, Yang Y, Popat A, Prow TW, Yu C. Nanodispersed UV blockers in skin-friendly silica vesicles with superior UV-attenuating efficiency. J Mater Chem B Mater Biol Med  2014; 2(44): 7673-8.
 [http://dx.doi.org/10.1039/C4TB01332H] [PMID:  32261903]

[109]
Chen-Yang YW, Chen YT, Li CC, et al. Preparation of UV-filter encapsulated mesoporous silica with high sunscreen ability. Mater Lett  2011; 65(6): 1060-2.
 [http://dx.doi.org/10.1016/j.matlet.2010.12.034]

[110]
Suh HW, Lewis J, Fong L, et al. Biodegradable bioadhesive nanoparticle incorporation of broad-spectrum organic sunscreen agents. Bioeng Transl Med  2019; 4(1): 129-40.
 [http://dx.doi.org/10.1002/btm2.10092] [PMID:  30680324]

[111]
Jaspart S, Piel G, Delattre L, Evrard B. Solid lipid microparticles: Formulation, preparation, characterisation, drug release and applications. Expert Opin Drug Deliv  2005; 2(1): 75-87.
 [http://dx.doi.org/10.1517/17425247.2.1.75] [PMID:  16296736]

[112]
Tursilli R, Piel G, Delattre L, Scalia S. Solid lipid microparticles containing the sunscreen agent, octyl-dimethylaminobenzoate: Effect of the vehicle. Eur J Pharm Biopharm  2007; 66(3): 483-7.
 [http://dx.doi.org/10.1016/j.ejpb.2007.02.017] [PMID:  17407809]

[113]
Gomaa YA, El-Khordagui LK, Boraei NA, Darwish IA. Chitosan microparticles incorporating a hydrophilic sunscreen agent. Carbohydr Polym  2010; 81(2): 234-42.
 [http://dx.doi.org/10.1016/j.carbpol.2010.02.024]

[114]
Yalavarthi PR, Dudala TB, Mudumala NL, et al. A perspective overview on lipospheres as lipid carrier systems. Int J Pharm Investig  2014; 4(4): 149-55.
 [http://dx.doi.org/10.4103/2230-973X.143112] [PMID:  25426435]

[115]
Deng Y, Ediriwickrema A, Yang F, Lewis J, Girardi M, Saltzman WM. A sunblock based on bioadhesive nanoparticles. Nat Mater  2015; 14(12): 1278-85.
 [http://dx.doi.org/10.1038/nmat4422] [PMID:  26413985]

[116]
Yener G, Incegül T, Yener N. Importance of using solid lipid microspheres as carriers for UV filters on the example octyl methoxy cinnamate. Int J Pharm  2003; 258(1-2): 203-7.
 [http://dx.doi.org/10.1016/S0378-5173(03)00203-5] [PMID:  12753766]
Rights & Permissions Print Cite
Article Metrics
30
6
Journal Information
For Authors
For Editors
For Reviewers
Explore Articles
Open Access
Open Access Articles
For Visitors
DOI https://dx.doi.org/10.2174/2589977515666230718124841	Print ISSN 2589-9775
Publisher Name Bentham Science Publisher	Online ISSN 2589-9783
Current Drug Research Reviews

Clinical Applications of Sunscreens and Formulation Advancements

Abstract

Graphical Abstract

Related Journals

Related Books

Related Articles
